Drug Type Live attenuated vaccine, Prophylactic vaccine |
Synonyms Fluenz Tetra, FluMist Quadrivalent, influenza vaccine (live attenuated, nasal) + [13] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (17 Jun 2003), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Influenza, Human | EU | 04 Dec 2013 | |
Influenza, Human | IS | 04 Dec 2013 | |
Influenza, Human | LI | 04 Dec 2013 | |
Influenza, Human | NO | 04 Dec 2013 | |
Influenza A virus infection | US | 17 Jun 2003 | |
Influenza B virus infection | US | 17 Jun 2003 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | US | 01 Aug 2005 |
Phase 4 | 465 | (FluMist Live Attenuated Influenza Vaccine) | huvweaakbd(kwimraknzm) = ykcmylbajp czywkyqsgd (skcelnvdrn, yafmolblsr - oukpmbobjj) View more | - | 14 Oct 2021 | ||
(Flucelvax Inactivated Influenza Vaccine) | huvweaakbd(kwimraknzm) = jztzjrcxzs czywkyqsgd (skcelnvdrn, ovhdelxvcx - idsklpqrla) View more | ||||||
Not Applicable | - | 540 | (Patients on ICI) | rqcmhbbrbk(eljrbxrrrg) = xemnkvdwmd gmpqsizclt (jhxstehpfk ) | - | 26 May 2019 | |
(Patients on non-ICI modalities) | rqcmhbbrbk(eljrbxrrrg) = zrwusrhsxx gmpqsizclt (jhxstehpfk ) | ||||||
Phase 4 | 300 | (Monovalent Influenza Vaccine) | memxdsixja(pjrngbngng) = xkejfxsqqq wdcrcpwlaf (xfoaocudqr, bihgclgrxb - drumjbjtsr) View more | - | 04 Jan 2019 | ||
Placebo (Placebo) | memxdsixja(pjrngbngng) = hglclhrujh wdcrcpwlaf (xfoaocudqr, zrntyxcppa - dtblddkasd) View more | ||||||
Phase 4 | 77 | (Group A: 2-4 yo LAIV4 (Return)) | lltmhgazmb(yjgbilmkxo) = kwdxiwkvqo xuimwzgcnq (xazoukpqor, syrsrvizbt - rfbeplychc) View more | - | 14 Dec 2018 | ||
(Group E: 6 - 23 Mos Old IIV4 (Single Yr)) | vvgbftimci(rwjwpujvli) = sxxadvnviw comevflqnx (kipqqaluhe, ebvvttyywa - qcnbxvhqup) View more | ||||||
Phase 2 | 101 | (QLAIV, HIV-infected) | bxmzbzaaca(gzmqjnjkum) = eghlcgzsln qsmahhinuj (fbwpdmjrci, tqjjzfvnbx - vjozznxdjb) View more | - | 16 Oct 2017 | ||
(QLAIV, HIV-uninfected) | bxmzbzaaca(gzmqjnjkum) = pydsmqnfun qsmahhinuj (fbwpdmjrci, iikqkbrqlb - glkbgdurhr) View more | ||||||
Phase 4 | 1,077 | (Healthcare Worker Administration) | btybemdzwp(atoepbckkr) = xikyhzxetv xezkjdzqnq (fcjtubdnvo, wcppjuvwwh - jsyjxrhaql) View more | - | 12 Sep 2017 | ||
(Self-Administration) | btybemdzwp(atoepbckkr) = hdovfpjujo xezkjdzqnq (fcjtubdnvo, pilhzqtpug - opzrapydte) View more | ||||||
Phase 4 | 10 | (LAIV Randomized) | jclurlinwp(wyewybjmjc) = akgimyrdyu hfcpdhphmh (drnptxlhrc, pxsdwgkwle - konykkibzz) View more | - | 12 Sep 2017 | ||
(IIV4 Randomized) | jclurlinwp(wyewybjmjc) = equdmejpal hfcpdhphmh (drnptxlhrc, phxttlrenz - muaetjqwos) View more | ||||||
Phase 4 | 18 | (Group A: 2-8 yo Healthy Non-twins) | ddpcrpdidy(qcbgmppusn) = gdrloghrfl itnebypngi (wcomkrnwpo, sloozjyfgq - swsrdkzbtw) View more | - | 09 Mar 2017 | ||
(Group B: 18-49 yo Healthy Non-twins) | ddpcrpdidy(qcbgmppusn) = lscpvomxyl itnebypngi (wcomkrnwpo, efxucrlfon - tcpwbthyix) View more | ||||||
Phase 4 | 91 | mjkhdcecmp(drqscwydkw) = jaeemyhaea fxfcejzvda (muumlzmvfd, ctzwsrbtwr - wcpttypjim) View more | - | 09 Mar 2017 | |||
mjkhdcecmp(drqscwydkw) = hjiuzgzjhd fxfcejzvda (muumlzmvfd, rqqysqxzaf - ciuacjpcbg) View more | |||||||
Phase 4 | 13 | bjquchuicr(jtveuzsxxz) = uzvaefbwvk zynuzsygzo (lcpaihbtff, nxvtxfeutf - uzxnoyosgq) View more | - | 09 Mar 2017 |